Terbinafine Hydrochloride Cream
Product Images NDC 51672-2080

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Terbinafine Hydrochloride (NDC 51672-2080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Terbinafine 01)

An anatomical illustration showing a close-up of a human foot focusing on the toes, highlighting a fungal infection on one toenail with a depiction of target marks on the affected nail and surrounding toes, likely intended to demonstrate the treatment area for topical antifungal medication.*

FDA Label Image

Figure 2 (Terbinafine 02)

An instructional illustration showing a human foot with target symbols on specific areas, likely indicating locations for topical application of the medication Terbinafine Hydrochloride cream.*

FDA Label Image

Principal Display Panel (30 g Carton)

Packaging label for Terbinafine Hydrochloride Cream 1%, an antifungal topical cream. The blue carton highlights the product name and strength prominently, stating it is for athlete's foot and provides full prescription strength. The labeler is Sun Pharmaceutical Industries, Inc., with distribution by Taro Pharmaceuticals U.S.A., Inc. The net weight is 1 oz (30 g).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.